Business Standard

Gold duty hike tackles symptom, not cause: Nomura

Gold imports are likely to ease to $44 billion in 2013-14 from an estimated $48.3 billion in 2012-13 in value terms

Related News

The government's move to hike gold import tax will only shift gold shipments to 'unofficial channels', said Nomura.

"Therefore, in our view imposing import duty tackles the symptom, not the cause," said in a note.

Gold imports are likely to ease to $44 billion in 2013-14 from an estimated $48.3 billion in 2012-13 in value terms, marking a 0.2 percentage point drop, Nomura estimates.

Nomura says current account deficit could moderate to 4.3% of in FY14 from an estimated 4.9% in FY13, "remaining above sustainable levels," due to high oil prices and continued domestic supply-side constraints that boost imports.

Read more on:   
|
|

Gold duty hike tackles symptom, not cause: Nomura

Gold imports are likely to ease to $44 billion in 2013-14 from an estimated $48.3 billion in 2012-13 in value terms

The government's move to hike gold import tax will only shift gold shipments to 'unofficial channels', said Nomura.

The government's move to hike gold import tax will only shift gold shipments to 'unofficial channels', said Nomura.

"Therefore, in our view imposing import duty tackles the symptom, not the cause," said in a note.

Gold imports are likely to ease to $44 billion in 2013-14 from an estimated $48.3 billion in 2012-13 in value terms, marking a 0.2 percentage point drop, Nomura estimates.

Nomura says current account deficit could moderate to 4.3% of in FY14 from an estimated 4.9% in FY13, "remaining above sustainable levels," due to high oil prices and continued domestic supply-side constraints that boost imports.

image

Read More

Gems & jewellery exports fall 17% in 2012

Rupee depreciation protects decline, exports to rise 15-20% next financial yearIndias gems and jewellery (G&J) exports declined 17.09 per cent in ...

Recommended for you

Quick Links

Market News

Nickel rises by 0.1% on Asian cues

Traders strengthened positions amid a firming Asian cues

Oil prices rise further in Asia

Expectations of a decline in US crude inventories and robust economic data from the eurozone helped prices

Markets remain rangebound; HUL up over 2%, Hindalco dips 1%

Investors are optimistic about a possible solution between Greece and its international creditors to avert a debt crisis

Pharma shares in focus; Aurobindo Pharma hits new high

JB Chemicals, Alembic Pharma, Aurobindo Pharma, Ipca Laboratories and Dishman Pharma were up 3%-11% each.

Infinite Computer gains on board approval for share buyback proposal

The stock spurted 5% at Rs 171 after the board approved the buyback of shares at a maximum price of Rs 220 per share from the open market ...

 

Back to Top